AU Patent

AU2015392050B2 — Fumarate of pyridylamine compound and crystals thereof

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2020-01-23 · 6y expired

What this patent protects

Disclosed are a fumarate, an A-type crystal and B-type crystal of a pyridylamine compound having the structural formula (III), a preparation method therefor, medicine compositions and crystal compositions containing the compound and the crystals thereof, and uses thereof in prepa…

USPTO Abstract

Disclosed are a fumarate, an A-type crystal and B-type crystal of a pyridylamine compound having the structural formula (III), a preparation method therefor, medicine compositions and crystal compositions containing the compound and the crystals thereof, and uses thereof in preparation of medicines for preventing or treating tumors.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015392050B2
Jurisdiction
AU
Classification
—
Expires
2020-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.